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Background
Systemic sclerosis is a immune mediated inflammatory
disease culminating in vasculopathy and extensive fibrosis
of the skin and internal organs. Telomere shortening has
previously been described in SSc.
Aim
To replicate previous findings in large cohort, investigate
telomere shortening in multiple immune celltypes and
scrutinize underlying aberrances in telosome gene
expression.
Methods
We measured telomere length by PCR in a cohort of
185 SSc patients and 100 healthy controls. Next we
investigated plasmacytoid dendritic cells, T cells, B cells,
monocytes and myeloid dendritic cells from 25 SSc
patients for cell specific telomere attrition. Finally we
investigated whether there were differences in expres-
sion of 31 genes involved in telomere pathways.
Results
We observed a significant age related telomere attrition
in healthy controls and lcSSc patients (Both p< 0.001),
but not in dcSSc patients. In the immune cell subset spe-
cific analysis we observed significant shorter telomeres in
B cells and myeloid dendritic cells of both lcSSc and
dcSSc patients (B-Cells p=0.014, p=0.002 & myDCs
p=0.019, p=0.004 respectively). PDCs and T cells were
significantly shorter in dcSSc patients only (p=0.001 and
p=0.003 respectively). In addition, we observed in early
SSc, that B cells exhibit a significant upregulation of the
telosome genes SIRT6, RIF1 and WRN (after correction
for multiple testing p=0.03, 0.006 and 0.048 respectively).
In later disease there is a significant higher expression of
HDAC9 in monocytes from dcSSc compared to lcSSc
patients. Intriguingly, in PDCs of diffuse SSc patients,
regardless whether it is early or progressed disease the
expression of SIRT1 is significantly lower (p=0.002 in all
comparisons).
Conclusions
Aberrances in telomere shortening and biology are a fea-
ture of SSc, reflecting a difference in clinical subsets at
the cellular level.
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